Survey of prevalence of diabetes mellitus and associated factors in out patients’ clinic Nishtar Hospital Multan.

Ayesha Siddiqua, Abdul Majeed, Muhammad Hanif


Aim of this study was to determine the awareness amongst Diabetic patients, its risk factors and complications. This was a cross-sectional survey conducted at the outpatient, Diabetic clinic Nishtar hospital, Multan in April of 2014. A structured and close ended questionnaire was administered and 300 patients of different age groups were interviewed about their knowledge regarding awareness of Diabetes Mellitus, complications and risk factors. Of the three hundred patients subjected to the survey, 18% individuals were aware of risk factors while 22% were aware of the complications associated with the disease.This awareness is significantly less in female as compared to male. Prevalence of risk factors and complication is greater in female particularly because of physical inactivity. Majority of patients had inadequate knowledge about Diabetes Mellitus and its associated risk factors. Public awareness and knowledge about disease can be raised by planning and implementing outreach programmes and mass media. Moreover, exercise benefits should be demonstrated in public.


Diabetes Mellitus, Diabetic complications, Risk factors, Exercise

Full Text:



Adlersberg D (1958). Obesity, fat metabolism and diabetes. Diabetes., 7: 236.

Boulé NG,Haddad E, Kenny GP, Wells GA and Sigal RJ (2001). Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials. JAMA., 286: 1218-1227.

Çaliskan D, Ozdemir O, Ocaktan E and Idil A (2006). Evaluation of awareness of diabetes mellitus and associated factors in four health center areas. Pat. edu. counsel., 62: 142-147.

The Diabetes Control and Complications Trial Research Group (1993). The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med., 329: 977-986.

Fezeu F, Fointama E, Ngufor G, Mbeh G and Mbanya J (2010). Diabetes awareness in general population in Cameroon. Dia. Res.Clin. Prac., 90: 312-318.

Ramachandran A, Ma RCW an Snehalatha C (2010). Diabetes in Asia. Lancet., 375: 408-418.

Sharif S, Ranjha NM, Majeed A, Abbas G, Ajmal MT, Hassan S, Aftab B, Hussain M and Rehman RU (2016). Survey of socio-demographic prevalence, risk factors and clinical characterization of tuberculosis in Nishtar Hospital Multan. Pak. J. Pharma. Res., 2: 8-14.

Shaw JE, Sicree RA and Zimmet PZ (2010). Global estimates of the prevalence of diabetes for 2010 and 2030. Dia. Res. Clin. Prac., 87: 4-14.

Turner RC, Cull CA, Frighi V and Holman RR (1999). Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). JAMA., 281: 2005-2012.

Varghese A, Asha NS, Celine TM and Prasanna D (2015). Inflammatory markers in Type II Diabetes mellitus. Pharma. Inno., 4:64-66

Yoon K., Lee JH, Kim JW, Cho JH, Choi YH, Ko SH, Zimmet P and Son HY (2006). Epidemic obesity and type 2 diabetes in Asia. Lancet., 368: 1681-1688.



  • There are currently no refbacks.

Copyright (c) 2017 Pakistan Journal of Pharmaceutical Research

Copyright © 2014 All Rights Reserved  Pakistan Journal of Pharmaceutical Research 
Powered by Department of Pharmacy BZU | Designed By: Muqeet Wahid